Comment on Ortler et al. (Pain 62 (1995) 357-361)
Department of Neurological Sciences, Fundação Curitiba Pro-Base do Cranio Hospital das Naçoes, Curitiba, P R, Brazil.
Walter Oleschko
WO
Arruda
Sonival C
SC
Hunbevicz
D000328:Adult; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007278:Injections, Spinal; D007403:Intervertebral Disc / Q000601:surgery*; D017116:Low Back Pain / Q000188:drug therapy; D008159:Lumbar Vertebrae / Q000601:surgery*; D008297:Male; D008776:Methylprednisolone Hemisuccinate / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D010149:Postoperative Pain / Q000188:drug therapy*; D013226:Status Epilepticus / Q000139:chemically induced*
D000893:Anti-Inflammatory Agents; D008776:Methylprednisolone Hemisuccinate